Patent US744481A successfully refreshed from Google Patents.
Patent US5205291A successfully refreshed from Google Patents.
US5205291A
Expired / Lapsed
US
⏱️ 0.0 years remaining
In vivo fluorescence photometer
Assignee: Health Research Inc
•
Filing: 1991-10-07
•
Granted: 1993-04-27
•
Expires: 2011-10-07
Abstract
Abstract A method and apparatus for in vivo detection of abnormal tissue in patients by irradiating a diagnostic region simultaneously with at least two wavelengths of incident light, and detecting the resulting fluorescence of normal and abnormal tissue. The patient is provided with a photosensitizer which preferentially collects in abnormal tissue, and beams of light--preferably at about 612 and 632.8 nm--are directed to the diagnostic region. The beams of light are chopped at 90 and 135 Hz, respectively. Fluorescent light from the diagnostic region is then detected, and an electronic signal is generated relating to the intensity of the fluorescence. Because of the chopping of the incident beams, the fluorescent light and the resulting electronic signal are also chopped. The electronic signal is provided as input to phase-locked amplifier circuitry, which differentiates between the contribution to the signal resulting from each of the 612 and 632.8 nm incident beams. A difference signal is provided as output to headphones, and the operator of the apparatus is notified of presence of abnormal tissue by changes in pitch of the difference signal. The source for the light may be lasers or an arc lamp, and there may be three or more incident wavelengths used.
Inventors
- 👤 William R. Potter
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 07:44
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61B; A61B5/00; A61B5/0059; A61B5/41; A61B5/414; A61B5/415; A61B5/418; A61N5/0601
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
148 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with an incident light of a first wavelength and an incident light of a second wavelength; detecting fluorescence at the diagnostic region in response to said incident light of said first and second wavelengths; determining a first contribution to the fluorescence from said light of the first wavelength and a second contribution to the fluorescence from said light of the second wavelength; differencing said first contribution and said second contribution to achieve a contribution difference; and generating an output from said contribution different for indicating presence of abnormal tissue at the diagnostic region; and wherein the illuminating step comprises interrupting said incident light of the first wavelength at a first frequency and said incident light of the second wavelength at a second frequency.
Claim 2
Independent Claim
148 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with an incident light of a first wavelength and an incident light of a second wavelength; detecting fluorescence at the diagnostic region in response to said incident light of said first and second wavelengths; determining a first contribution to the fluorescence from said light of the first wavelength and a second contribution to the fluorescence from said light of the second wavelength; differencing said first contribution and said second contribution to achieve a contribution difference; and generating an output from said contribution different for indicating presence of abnormal tissue at the diagnostic region; and wherein the illuminating step comprises interrupting said incident light of the first wavelength at a first frequency and said incident light of the second wavelength at a second frequency.
Claim 3
Dependent Claim
72 words
The method of claim 1, wherein the determining step comprises the steps of generating a first fluorescence intensity signal relating to intensities of the fluorescence resulting from responsive to said incident light of said first wavelength, and generating a second fluorescence intensity signal responsive to said incident light of said second wavelength; and wherein the contribution difference comprises a difference signal generated by subtracting said second signal relative to said first signal.
Claim 4
Dependent Claim
35 words
The method of claim 2, wherein said first wavelength is selected so as to minimize resulting fluorescence from abnormal tissue, and said second wavelength is selected so as to maximize resulting fluorescence from abnormal tissue.
Claim 5
Dependent Claim
22 words
The method of claim 3, wherein said first and second wavelengths are selected to maximize penetration of tissue by said incident lights.
Claim 6
Dependent Claim
35 words
A method of claim 3, wherein said first and second wavelengths are selected such that said first contribution and said second contribution to fluorescence intensity are substantially equal at a diagnostic region of normal tissue.
Claim 7
Dependent Claim
29 words
The method of claim 5, wherein said second contribution to fluorescence intensity is substantially greater than said first contribution to fluorescence intensity at a diagnostic region of abnormal tissue.
Claim 8
Dependent Claim
32 words
The method of claim 5, wherein the drug induces fluorescence in the region of 690 nm wavelength, the first wavelength is approximately 610 nm, and the second wavelength is approximately 630 nm.
Claim 9
Dependent Claim
11 words
The method of claim 7, wherein the drug is Photofrin II.
Claim 10
Dependent Claim
51 words
The method of claim 3, wherein: said drug induces a fluorescent response in normal tissue including a series of intensity peaks; said first wavelength is selected to be adjacent to a selected one of said peaks; and said second wavelength is selected to be at a crest of said selected peak.
Claim 11
Dependent Claim
66 words
The method of claim 9, wherein said selected peak is selected to maximize transmission of said incident lights of said first and second wavelengths in said tissues while maintaining sufficient difference in intensity between the fluorescent responses from illuminating said normal and abnormal tissues with said incident lights of said first and second wavelengths such that said abnormal tissue may be differentiated from said normal tissue.
Claim 12
Dependent Claim
13 words
The method of claim 1, wherein the method is carried out in vivo.
Claim 13
Dependent Claim
17 words
The method of claim 1, wherein the second frequency is an odd half-multiple of the first frequency.
Claim 14
Dependent Claim
19 words
The method of claim 12, wherein the first frequency is 90 Hz and the second frequency is 135 Hz.
Claim 15
Independent Claim
175 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with a first incident light of a first wavelength and a second incident light of a second wavelength; detecting fluorescence at said diagnostic region in response to said incident lights; determining a first contribution to the fluorescence from said first incident light and a second contribution to the fluorescence from said second incident light differencing said first contribution and said second contribution; generating an output from said first contribution and said second contribution for indicating presence of abnormal tissue at the diagnostic region; wherein said illuminating step is carried out by an arc lamp having a broad emission spectrum; wherein said first and second incident lights are generated by passing the emission spectrum through a diffraction grating having at least two slits; wherein said diffraction grating passes said first incident light at a wavelength of approximately 610 nm, and said second incident light at a wavelength of approximately 632 nm.
Claim 16
Independent Claim
175 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with a first incident light of a first wavelength and a second incident light of a second wavelength; detecting fluorescence at said diagnostic region in response to said incident lights; determining a first contribution to the fluorescence from said first incident light and a second contribution to the fluorescence from said second incident light differencing said first contribution and said second contribution; generating an output from said first contribution and said second contribution for indicating presence of abnormal tissue at the diagnostic region; wherein said illuminating step is carried out by an arc lamp having a broad emission spectrum; wherein said first and second incident lights are generated by passing the emission spectrum through a diffraction grating having at least two slits; wherein said diffraction grating passes said first incident light at a wavelength of approximately 610 nm, and said second incident light at a wavelength of approximately 632 nm.
Claim 17
Independent Claim
182 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with a first incident light of a first wavelength and a second incident light of a second wavelength; detecting fluorescence at said diagnostic region in response to said incident lights; determining a first contribution to the fluorescence from said first incident light and a second contribution to the fluorescence from said second incident light; differencing said first contribution and said second contribution; and generating an output from said first contribution and said second contribution for indicating presence of abnormal tissue at the diagnostic region; and wherein said illuminating step is carried out by an arc lamp having a broad emission spectrum; and wherein said first incident light is generated by passing said emission spectrum through a first interference filter resulting in incident light at a wavelength of approximately 610 nm, and second incident light is generated by passing said emission spectrum through a second interference filter resulting in incident light at a wavelength of approximately 632 nm.
Claim 18
Independent Claim
182 words
A method for detecting abnormal tissue in a patient, including the steps of: introducing a photosensitizing drug into the patient; illuminating a diagnostic region simultaneously with a first incident light of a first wavelength and a second incident light of a second wavelength; detecting fluorescence at said diagnostic region in response to said incident lights; determining a first contribution to the fluorescence from said first incident light and a second contribution to the fluorescence from said second incident light; differencing said first contribution and said second contribution; and generating an output from said first contribution and said second contribution for indicating presence of abnormal tissue at the diagnostic region; and wherein said illuminating step is carried out by an arc lamp having a broad emission spectrum; and wherein said first incident light is generated by passing said emission spectrum through a first interference filter resulting in incident light at a wavelength of approximately 610 nm, and second incident light is generated by passing said emission spectrum through a second interference filter resulting in incident light at a wavelength of approximately 632 nm.
References Cited (Backward Citations)
US5111821A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-04-26 | 1996-10-26 | 1997-04-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-04-26 | 2000-10-26 | 2001-04-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-04-26 | 2004-10-26 | 2005-04-27 | $7700.00 | Window Closed / Lapsed |